Shukra Pharmaceuticals Limited (SHUKRAPHAR.BO)
INR 96.94
(4.99%)
INR 96.94
(4.99%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 31.53 Million INR | -37.93% |
| 2022 | 50.81 Million INR | 50.5% |
| 2021 | 33.76 Million INR | -65.44% |
| 2020 | 97.7 Million INR | 21.35% |
| 2019 | 80.51 Million INR | 25.69% |
| 2018 | 64.05 Million INR | 71.17% |
| 2017 | 37.42 Million INR | 10295.84% |
| 2016 | 360 Thousand INR | 0.0% |
| 2015 | 360 Thousand INR | -96.99% |
| 2014 | 11.96 Million INR | 284.57% |
| 2013 | 3.11 Million INR | -96.93% |
| 2012 | 101.17 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q2 | 23.06 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 31.53 Million INR | -37.93% |
| 2023 Q4 | 31.53 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 50.81 Million INR | 0.0% |
| 2022 FY | 50.81 Million INR | 50.5% |
| 2022 Q2 | 17.31 Million INR | 0.0% |
| 2021 Q4 | 33.76 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 33.76 Million INR | -65.44% |
| 2021 Q2 | 104.69 Million INR | 0.0% |
| 2020 Q4 | 97.7 Million INR | 0.0% |
| 2020 FY | 97.7 Million INR | 21.35% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 96.1 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2019 FY | 80.51 Million INR | 25.69% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q4 | 80.51 Million INR | 0.0% |
| 2018 Q4 | 60.56 Million INR | 0.0% |
| 2018 Q2 | 49.56 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2018 FY | 64.05 Million INR | 71.17% |
| 2017 FY | 37.42 Million INR | 10295.84% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q2 | 20.98 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 Q4 | 35.83 Million INR | 0.0% |
| 2016 Q1 | 360 Thousand INR | 0.0% |
| 2016 FY | 360 Thousand INR | 0.0% |
| 2016 Q4 | 360 Thousand INR | 0.0% |
| 2016 Q3 | 360 Thousand INR | 0.0% |
| 2016 Q2 | 360 Thousand INR | 0.0% |
| 2015 Q2 | - INR | -100.0% |
| 2015 FY | 360 Thousand INR | -96.99% |
| 2015 Q4 | 360 Thousand INR | 0.0% |
| 2015 Q3 | 360 Thousand INR | 0.0% |
| 2015 Q1 | 2.15 Million INR | -82.02% |
| 2014 Q4 | 11.96 Million INR | -5.08% |
| 2014 Q1 | 2.61 Million INR | -16.08% |
| 2014 FY | 11.96 Million INR | 284.57% |
| 2014 Q3 | 12.6 Million INR | 13.51% |
| 2014 Q2 | 11.1 Million INR | 325.29% |
| 2013 Q3 | 101.63 Million INR | 0.09% |
| 2013 Q4 | 3.11 Million INR | -96.94% |
| 2013 FY | 3.11 Million INR | -96.93% |
| 2013 Q2 | 101.53 Million INR | 0.12% |
| 2013 Q1 | 101.41 Million INR | 0.24% |
| 2012 Q4 | 101.17 Million INR | 0.0% |
| 2012 Q3 | - INR | -100.0% |
| 2012 Q2 | 105.75 Million INR | 0.0% |
| 2012 FY | 101.17 Million INR | 0.0% |
| 2011 Q4 | 104.93 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.56 Million INR | -23.375% |
| KIMIA BIOSCIENCES LIMITED | 437.07 Million INR | 92.784% |
| SHELTER PHARMA LIMITED | 5.77 Million INR | -446.319% |
| Vasundhara Rasayans Limited | 19.46 Million INR | -62.029% |
| Sunil Healthcare Limited | 661.51 Million INR | 95.232% |
| Chemo Pharma Laboratories Limited | - INR | -Infinity% |
| MedPlus Health Services Limited | 10.09 Billion INR | 99.688% |
| Bharat Immunologicals & Biologicals Corporation Limited | 702.24 Million INR | 95.509% |
| Patidar Buildcon Limited | 25.32 Million INR | -24.547% |
| Roopa Industries Limited | 258.54 Million INR | 87.801% |
| Smruthi Organics Limited | 117.03 Million INR | 73.051% |
| Trident Lifeline Limited | 184.1 Million INR | 82.869% |
| PANJON LTD. | 14.36 Million INR | -119.493% |
| Pharmaids Pharmaceuticals Limited | 85.32 Million INR | 63.038% |
| Gujarat Terce Laboratories Limited | 38.66 Million INR | 18.43% |
| TIAAN CONSUMER LIMITED | 14.8 Million INR | -113.101% |
| Anuh Pharma Limited | 26.92 Million INR | -17.123% |
| Crestchem Limited | - INR | -Infinity% |
| Emmessar Biotech & Nutrition Limited | 1.09 Million INR | -2782.907% |
| Sandu Pharmaceuticals Limited | 633 Thousand INR | -4882.464% |
| Tyche Industries Limited | - INR | -Infinity% |
| Fredun Pharmaceuticals Limited | 1.05 Billion INR | 97.011% |
| Trimurthi Limited | - INR | -Infinity% |
| Norris Medicines Limited | 215.23 Million INR | 85.347% |
| Zenlabs Ethica Limited | 148.59 Million INR | 78.775% |
| Vikram Thermo (India) Limited | 70.43 Million INR | 55.224% |
| ANG Lifesciences India Limited | 728.36 Million INR | 95.67% |
| Parmax Pharma Limited | 53.72 Million INR | 41.293% |
| Veerhealth Care Limited | - INR | -Infinity% |
| Deccan Health Care Limited | 18.95 Million INR | -66.424% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.04 Billion INR | 96.992% |
| Makers Laboratories Limited | 194.92 Million INR | 83.82% |
| Lactose (India) Limited | 392.52 Million INR | 91.965% |
| OXYGENTA PHARMACEUTICAL LIMITE | 572.33 Million INR | 94.489% |
| Zenith Healthcare Limited | - INR | -Infinity% |
| Sanjivani Paranteral Limited. | 9.69 Million INR | -225.446% |
| Bacil Pharma Limited | 984 Thousand INR | -3105.183% |
| PRAVEG LIMITED | 596.11 Million INR | 94.709% |
| Denis Chem Lab Limited | 10.46 Million INR | -201.52% |
| Kwality Pharmaceuticals Limited | 981.19 Million INR | 96.786% |
| Jenburkt Pharmaceuticals Limited | - INR | -Infinity% |
| Colinz Laboratories Limited | 5.69 Million INR | -453.51% |
| Godavari Drugs Limited | 556.24 Million INR | 94.33% |
| SHAMROCK INDUSTRIAL CO.LTD. | - INR | -Infinity% |
| Zenotech Laboratories Limited | - INR | -Infinity% |
| Panchsheel Organics Limited | 63.09 Million INR | 50.01% |
| Shree Ganesh Remedies Limited | 364.49 Million INR | 91.347% |
| Vivanza Biosciences Limited | 51.69 Million INR | 38.99% |
| Phaarmasia Limited | 1.44 Million INR | -2088.688% |
| Sastasundar Ventures Limited | 38.82 Million INR | 18.773% |
| Medi-Caps Limited | - INR | -Infinity% |
| DECIPHER LABS LIMITED | - INR | -Infinity% |
| Gujarat Themis Biosyn Limited | 27.68 Million INR | -13.925% |
| Ambalal Sarabhai Enterprises Limited | 461.12 Million INR | 93.16% |
| Mercury Laboratories Limited | 55.53 Million INR | 43.21% |
| Gennex Laboratories Limited | 57.2 Million INR | 44.867% |
| BDH Industries Limited | 86.9 Million INR | 63.709% |
| Coral Laboratories Limited | - INR | -Infinity% |
| Concord Drugs Limited | 165.94 Million INR | 80.994% |
| Bharat Parenterals Limited | 1.57 Billion INR | 97.999% |
| Beryl Drugs Limited | 50.93 Million INR | 38.085% |
| Vista Pharmaceuticals Limited | 79.64 Million INR | 60.402% |
| Evoq Remedies Limited | 42.38 Million INR | 25.584% |
| Add-Shop E-Retail Limited | 127.73 Million INR | 75.31% |
| Transchem Limited | - INR | -Infinity% |
| Ishita Drugs and Industries Limited | - INR | -Infinity% |
| Parnax Lab Limited | 806.38 Million INR | 96.089% |
| Source Natural Foods and Herbal Supplements Limited | 35 Thousand INR | -90011.429% |
| Kerala Ayurveda Limited | 675.77 Million INR | 95.333% |
| Cian Healthcare Limited | 556.91 Million INR | 94.337% |
| Trinity League India Limited | 242 Thousand INR | -12932.645% |
| Syschem (India) Limited | 4.5 Million INR | -600.867% |
| KOBO BIOTECH LIMITED | 1.39 Billion INR | 97.742% |
| Natural Capsules Limited | 1.09 Billion INR | 97.107% |
| Auro Laboratories Limited | 262.43 Million INR | 87.982% |